Publication | Closed Access

Impact of genetic SLC28 transporter and ITPA variants on ribavirin serum level, hemoglobin drop and therapeutic response in patients with HCV infection

Itpa VariantsViral HepatitisImmunologyAntiviral TherapyHepatitisVirologyRibavirin Serum LevelChronic Viral InfectionAntiviral DrugGenetic Slc28 TransporterMedicine